During the past decade, Institute of HIV Research and Innovation conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of HIV Research and Innovation" #1 sponsor was "Institute of HIV Research and Innovation Foundation, Thailand" with 4 trials, followed by "Thai Red Cross AIDS Research Centre" with 3 trials sponsored, "University of Massachusetts, Worcester" with 2 trials sponsored, "Global Antibiotics Research and Development Partnership" with 1 trials sponsored and "University of Toronto" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of HIV Research and Innovation" #1 collaborator was "amfAR, The Foundation for AIDS Research" with 3 trials as a collaborator, "Institute of HIV Research and Innovation Foundation, Thailand" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Wayne State University" with 2 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Institute of HIV Research and Innovation" are "Drug Interaction" (2 trials), "HIV" (2 trials), "Pre-Exposure Prophylaxis" (2 trials), "Anal High-grade Squamous Intraepithelial Lesion" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Institute of HIV Research and Innovation" in a lesser frequency.

Most popular intervention types in "Institute of HIV Research and Innovation" are "Behavioral" (4 trials), "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Standard PrEP Counseling" (2 trials), "Behavioral: Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP)" (1 trials), "Depression Screening Intervention" (1 trials), "Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)" (1 trials) and "Enhanced YaCool" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of HIV Research and Innovation" are 6 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institute of HIV Research and Innovation". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute of HIV Research and Innovation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of HIV Research and Innovation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".